Price, D., Fox, H., Surrey, K., & Reisner, C. (2006). ABS38: Add-on omalizumab significantly improves quality of life in patients with severe persistent allergic (IgE-mediated) asthma. Prim Care Respir J.
Citación estilo ChicagoPrice, D., H. Fox, K. Surrey, and C. Reisner. "ABS38: Add-on Omalizumab Significantly Improves Quality of Life in Patients With Severe Persistent Allergic (IgE-mediated) Asthma." Prim Care Respir J 2006.
Cita MLAPrice, D., H. Fox, K. Surrey, and C. Reisner. "ABS38: Add-on Omalizumab Significantly Improves Quality of Life in Patients With Severe Persistent Allergic (IgE-mediated) Asthma." Prim Care Respir J 2006.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.